Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Multiple Myeloma 420Precursor Cell Lymphoblastic Leukemia-Lymphoma 126Neoplasms, Plasma Cell 74Recurrence 70Lymphoma 57Leukemia 54Neoplasms 46Immunoglobulin Light-chain Amyloidosis 38Burkitt Lymphoma 37Vomiting 36Lymphoma, Mantle-Cell 32Lymphoma, Large B-Cell, Diffuse 31Nausea 29Lymphoma, Non-Hodgkin 28Breast Neoplasms 22Waldenstrom Macroglobulinemia 21Lymphoma, Follicular 21Hodgkin Disease 21Leukemia, Lymphocytic, Chronic, B-Cell 20Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17Neoplasm Metastasis 17Prostatic Neoplasms 16Lymphoma, Extranodal NK-T-Cell 16Amyloidosis 16Leukemia, Myeloid, Acute 15Smoldering Multiple Myeloma 14Lymphoma, B-Cell, Marginal Zone 13Lung Neoplasms 11Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, B-Cell 10

Interventions

Gemcitabine 9Carboplatin 8Paclitaxel 7Capecitabine 7Irinotecan 6pembrolizumab 3Radiotherapy 3Oxaliplatin 3Fluorouracil 3Filgrastim 3Cisplatin 3Bevacizumab 3etoposide phosphate 2Surveys and Questionnaires 2Peripheral Blood Stem Cell Transplantation 2Magnetic Resonance Spectroscopy 2Leucovorin 2Genetic Testing 2FAPI-46 2Etoposide 2Erlotinib Hydrochloride 2Docetaxel 2Cyclophosphamide 2Amifostine 2Albumin-Bound Paclitaxel 2tislelizumab 1tegafur-gimeracil-oteracil 1spartalizumab 1sintilimab 1erythromycin propionate-N-acetylcysteinate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplasms, Unknown Primary × Dexamethasone × Clear all
NCT04189107 2023-03-16

Postoperative Pain, Why Still in Hospital and DAOH Following TORS for SCCUP & OSAS

Rigshospitalet, Denmark

Phase 3 Completed
18 enrolled
Head & Neck

Agnosia, Head and Neck Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡